Literature DB >> 15265456

Issues in the Management of Endocarditis Caused by Resistant Gram-positive Organisms.

Martin E. Stryjewski1, Vivian H. Chu, Christopher H. Cabell, Vance G. Fowler.   

Abstract

Most cases of infective endocarditis (IE) are caused by gram-positive bacteria such as enterococci, streptococci, and staphylococci. Increasing resistance among these organisms has eroded the utility of mainstay antibiotics and complicated the management of this difficult-to-treat infection. Clinical experience with newer gram-positive antibiotics to treat IE is limited.

Entities:  

Year:  2004        PMID: 15265456     DOI: 10.1007/s11908-004-0049-7

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  70 in total

1.  Successful treatment of vancomycin-resistant Enterococcus faecium bacteremia with linezolid after failure of treatment with synercid (quinupristin/dalfopristin).

Authors:  S A McNeil; N M Clark; P H Chandrasekar; C A Kauffman
Journal:  Clin Infect Dis       Date:  2000-02       Impact factor: 9.079

2.  Endocarditis due to enterococcus faecalis: risk factors and outcome in twenty-one cases from a five year national survey.

Authors:  V Hricak; J Kovacik; P Marx; V Fischer; V Krcmery
Journal:  Scand J Infect Dis       Date:  1998

Review 3.  Penicillin-resistant Streptococcus pneumoniae endocarditis: a case report and review.

Authors:  M Siegel; J Timpone
Journal:  Clin Infect Dis       Date:  2001-03-09       Impact factor: 9.079

4.  Effectiveness of cloxacillin with and without gentamicin in short-term therapy for right-sided Staphylococcus aureus endocarditis. A randomized, controlled trial.

Authors:  E Ribera; J Gómez-Jimenez; E Cortes; O del Valle; A Planes; T Gonzalez-Alujas; B Almirante; I Ocaña; A Pahissa
Journal:  Ann Intern Med       Date:  1996-12-15       Impact factor: 25.391

5.  Enterococcal endocarditis in Sweden, 1995-1999: can shorter therapy with aminoglycosides be used?

Authors:  Lars Olaison; Kimmo Schadewitz
Journal:  Clin Infect Dis       Date:  2001-12-07       Impact factor: 9.079

6.  Effective treatment of multidrug-resistant enterococcal experimental endocarditis with combinations of cell wall-active agents.

Authors:  C M Brandt; M S Rouse; N W Laue; C W Stratton; W R Wilson; J M Steckelberg
Journal:  J Infect Dis       Date:  1996-04       Impact factor: 5.226

7.  Successful treatment of persistent bacteremia due to vancomycin-resistant, ampicillin-resistant Enterococcus faecium.

Authors:  E T Mekonen; G A Noskin; D M Hacek; L R Peterson
Journal:  Microb Drug Resist       Date:  1995       Impact factor: 3.431

Review 8.  Native valve Staphylococcus epidermidis endocarditis: report of seven cases and review of the literature.

Authors:  N Arber; A Militianu; A Ben-Yehuda; N Krivoy; J Pinkhas; Y Sidi
Journal:  Am J Med       Date:  1991-06       Impact factor: 4.965

9.  Treatment of streptomycin-susceptible and streptomycin-resistant enterococcal endocarditis.

Authors:  W R Wilson; C J Wilkowske; A J Wright; M A Sande; J E Geraci
Journal:  Ann Intern Med       Date:  1984-06       Impact factor: 25.391

10.  Right-sided Staphylococcus aureus endocarditis in intravenous drug abusers: two-week combination therapy.

Authors:  H F Chambers; R T Miller; M D Newman
Journal:  Ann Intern Med       Date:  1988-10-15       Impact factor: 25.391

View more
  1 in total

Review 1.  Vancomycin revisited - 60 years later.

Authors:  Ethan Rubinstein; Yoav Keynan
Journal:  Front Public Health       Date:  2014-10-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.